Skip to content
OncLive.com· @OncLive · X·· 2 days agoScore45

#PCSM

Body · original

🗣️ Kicking things off with Johanna S. Enke, MD of @UCLAHealthJCCC discussing a trial evaluating lutetium Lu 177 vipivotide tetraxetan in prostate cancer.

More overage on our site!

#ESMO26 @myESMO #pcsm #oncology

278 views · 1 like · 1 repost · 0 replies

Source: OncLive.com · x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org